Back
BioLine Rx Stock Predictions
Sponsored
BLRX
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
32
BLRX
BioLine Rx
Last Price:
0.43
Seasonality Move:
4.46%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeBioLine Rx Stock Forecast
-
Is BioLine Rx Stock Undervalued?
The current BioLine Rx [BLRX] share price is $0.43. The Score for BLRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal. - BLRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will BioLine Rx Stock Go Up Next Year?
Data Unavailable
BioLine Rx Stock Rating
Data Unavailable
BioLine Rx Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biolinerx.com
52-Week Data
52-Week High:
1.93
52-Week Low:
0.39
Prediction Charts
Market Cap:
34.17M
Price in USD:
0.43
Volume:
336.2K
Beta:
1.76
Technical Analysis
SMA50:
0.55
SMA100:
0.62
SMA200:
0.78
52-Wk Change:
-73.78%
Stock Predictions
-
Is BioLine Rx stock public?
Yes, BioLine Rx is a publicly traded company. -
What is the BioLine Rx stock quote today?
The BioLine Rx stock price is 0.43 USD today. -
How to buy BioLine Rx stock online?
You can buy BioLine Rx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-15 | 0.46 | 0.44 | 0.48 | 0.43 |
Oct-16 | 0.45 | 0.47 | 0.48 | 0.45 |
Oct-18 | 0.46 | 0.47 | 0.49 | 0.45 |
Oct-21 | 0.47 | 0.47 | 0.49 | 0.44 |
Oct-22 | 0.47 | 0.45 | 0.47 | 0.40 |
Oct-23 | 0.45 | 0.42 | 0.45 | 0.42 |
Oct-24 | 0.42 | 0.40 | 0.45 | 0.39 |
Oct-25 | 0.40 | 0.41 | 0.42 | 0.39 |
Oct-28 | 0.43 | 0.44 | 0.45 | 0.42 |
Oct-29 | 0.43 | 0.43 | 0.44 | 0.43 |
Oct-30 | 0.44 | 0.43 | 0.45 | 0.41 |
Oct-31 | 0.41 | 0.41 | 0.43 | 0.40 |
Nov-1 | 0.40 | 0.43 | 0.43 | 0.40 |
Nov-4 | 0.41 | 0.43 | 0.45 | 0.41 |
BioLine Rx Earnings
Data Unavailable
BioLine Rx Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.
* BioLine Rx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.